Xenon Pharmaceuticals Inc.


3650 Gilmore WayBurnabyBritish ColumbiaV5G 4W8Canada View Map


$1.8 Million



SIC Codes:

2834, 2835

NAICS Codes:

325412, 325414


(604) 484-3300


(604) 484-3450


We focus on the development of novel medicines using our proprietary Extreme Genetics® platform. We are a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan indications that we intend to commercialize on our own, and for larger market indications that we intend to partner with global pharmaceutical industry leaders. We have built a core platform, which we call Extreme Genetics®, enabling the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies. Our integrated platform has a full complement of in-house capabilities for human genetics and small molecule drug discovery, and for pre-clinical and clinical development.

Read More


Recently Updated profiles at this company

President and Chief Executive Officer

Chief Financial Officer and Chief Operating Officer

Research Scientist

Senior Principal Scientist

Vice President, Clinical Development

Chief Technology Officer and Head of Research and Development

Senior Vice President, Business and Corporate Development

Executive Assistant

Corporate Development

Project Manager

Browse ZoomInfo’s Directories